# Preoperative Intravesical Electromotive Mitomycin-c for Primary Non-muscle Invasive Bladder Cancer

> **NCT01149174** · PHASE3 · COMPLETED · sponsor: **University of Rome Tor Vergata** · enrollment: 352 (actual)

## Conditions studied

- Superficial Bladder Cancer

## Interventions

- **DRUG:** Mitomycin-C 40 mg

## Key facts

- **NCT ID:** NCT01149174
- **Lead sponsor:** University of Rome Tor Vergata
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1994-01
- **Primary completion:** 2003-12
- **Final completion:** 2009-06
- **Target enrollment:** 352 (ACTUAL)
- **Last updated:** 2011-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01149174

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01149174, "Preoperative Intravesical Electromotive Mitomycin-c for Primary Non-muscle Invasive Bladder Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01149174. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*